In consideration of the above, we initiated this current study to assess the possible role of sema3A in systemic lupus erythematosus (SLE), namely to measure its serum level in SLE patients and assess whether this level correlates with disease status. The gene discussed is SEMA3A; the disease is systemic lupus erythematosus.